FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2044349239> ?p ?o ?g. }

• W2044349239 abstract "Abstract Background It has been suggested that inactivation of p14 ARF , a tumor suppressor central to regulating p53 protein stability through interaction with the MDM2 oncoprotein, abrogates p53 activity in human tumors retaining the wild-type TP53 gene. Differences in expression of tumor suppressor genes are frequently associated with cancer. We previously reported on a pattern of restricted p53 immunohistochemical overexpression significantly associated with microsatellite instability (MSI), low TP53 mutation frequency, and MDM2 overexpression in colorectal cancers (CRCs). In this study, we investigated whether p14 ARF alterations could be a mechanism for disabling the p53 pathway in this subgroup of CRCs. Results Detailed maps of the alterations in the p14 ARF gene were determined in a cohort of 98 CRCs to detect both nucleotide and copy-number changes. Methylation-specific PCR combined with bisulfite sequencing was used to evaluate the prevalence and distribution of p14 ARF methylation. p14 ARF alterations were then correlated with MSI status, TP53 mutations, and immunohistochemical expression of p53 and MDM2. The frequency of p14 ARF mutations was extremely low (1/98; 1%), whereas coexistence of methylated and unmethylated alleles in both tumors and normal colon mucosa was common (91/98; 93%). Only seven of ninety-eight tumors (7%) had a distinct pattern of methylation compared with normal colon mucosa. Evaluation of the prevalence and distribution of p14 ARF promoter methylation in a region containing 27 CpG sites in 35 patients showed a range of methylated CpG sites in tumors (0 to 25 (95% CI 1 to 13) versus 0 to 17 (95% CI 0 to 2)) in adjacent colon mucosa ( P = 0.004). Hypermethylation of the p14 ARF promoter was significantly correlated with the restricted p53 overexpression pattern ( P = 0.03), and MDM2 overexpression (P = 0.02), independently of MSI phenotype. Although no significant correlation between p14 ARF methylation and TP53 mutational status was seen ( P = 0.23), methylation involving the proximal CpG sites within the 5′ CpG flanking exon 1β was present more frequently in tumors with restricted p53 overexpression than in those with diffuse p53 overexpression (range of methylated clones 17 to 36% (95% CI 24 to 36%) versus range 0 to 3% (95% CI 0 to 3%), P = 0. 0003). Conclusion p14 ARF epigenetic silencing may represent an important deregulating mechanism of the p53-MDM2-p14 ARF pathway in CRCs exhibiting a restricted p53 overexpression pattern." @default.
• W2044349239 created "2016-06-24" @default.
• W2044349239 creator A5009831353 @default.
• W2044349239 creator A5015094515 @default.
• W2044349239 creator A5017975921 @default.
• W2044349239 creator A5038323559 @default.
• W2044349239 creator A5051351549 @default.
• W2044349239 date "2012-06-15" @default.
• W2044349239 modified "2023-10-06" @default.
• W2044349239 title "RETRACTED ARTICLE: Hypermethylation of the 5′ CpG island of the p14ARF flanking exon 1β in human colorectal cancer displaying a restricted pattern of p53 overexpression concomitant with increased MDM2 expression" @default.
• W2044349239 cites W1502690833 @default.
• W2044349239 cites W1574325035 @default.
• W2044349239 cites W1596185088 @default.
• W2044349239 cites W1639710168 @default.
• W2044349239 cites W1650797637 @default.
• W2044349239 cites W1968263601 @default.
• W2044349239 cites W1973821009 @default.
• W2044349239 cites W1974138460 @default.
• W2044349239 cites W1979273476 @default.
• W2044349239 cites W1990823023 @default.
• W2044349239 cites W1993170641 @default.
• W2044349239 cites W1994465394 @default.
• W2044349239 cites W2003108314 @default.
• W2044349239 cites W2004342375 @default.
• W2044349239 cites W2004706142 @default.
• W2044349239 cites W2008887283 @default.
• W2044349239 cites W2009489886 @default.
• W2044349239 cites W2009973559 @default.
• W2044349239 cites W2017497141 @default.
• W2044349239 cites W2032918048 @default.
• W2044349239 cites W2035939797 @default.
• W2044349239 cites W2040260715 @default.
• W2044349239 cites W2040876807 @default.
• W2044349239 cites W2054961220 @default.
• W2044349239 cites W2058659363 @default.
• W2044349239 cites W2070508283 @default.
• W2044349239 cites W2073576377 @default.
• W2044349239 cites W2087791044 @default.
• W2044349239 cites W2097795604 @default.
• W2044349239 cites W2098652713 @default.
• W2044349239 cites W2102850127 @default.
• W2044349239 cites W2112299199 @default.
• W2044349239 cites W2113926943 @default.
• W2044349239 cites W2115290061 @default.
• W2044349239 cites W2116507825 @default.
• W2044349239 cites W2121228733 @default.
• W2044349239 cites W2139122477 @default.
• W2044349239 cites W2164004777 @default.
• W2044349239 cites W2165134145 @default.
• W2044349239 cites W2169793983 @default.
• W2044349239 cites W2278955805 @default.
• W2044349239 doi "https://doi.org/10.1186/1868-7083-4-9" @default.
• W2044349239 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3470942" @default.
• W2044349239 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22703554" @default.
• W2044349239 hasPublicationYear "2012" @default.
• W2044349239 type Work @default.
• W2044349239 sameAs 2044349239 @default.
• W2044349239 citedByCount "12" @default.
• W2044349239 countsByYear W20443492392013 @default.
• W2044349239 countsByYear W20443492392015 @default.
• W2044349239 countsByYear W20443492392016 @default.
• W2044349239 countsByYear W20443492392017 @default.
• W2044349239 countsByYear W20443492392018 @default.
• W2044349239 countsByYear W20443492392019 @default.
• W2044349239 countsByYear W20443492392020 @default.
• W2044349239 countsByYear W20443492392021 @default.
• W2044349239 countsByYear W20443492392022 @default.
• W2044349239 crossrefType "journal-article" @default.
• W2044349239 hasAuthorship W2044349239A5009831353 @default.
• W2044349239 hasAuthorship W2044349239A5015094515 @default.
• W2044349239 hasAuthorship W2044349239A5017975921 @default.
• W2044349239 hasAuthorship W2044349239A5038323559 @default.
• W2044349239 hasAuthorship W2044349239A5051351549 @default.
• W2044349239 hasBestOaLocation W20443492391 @default.
• W2044349239 hasConcept C104317684 @default.
• W2044349239 hasConcept C121608353 @default.
• W2044349239 hasConcept C140173407 @default.
• W2044349239 hasConcept C150194340 @default.
• W2044349239 hasConcept C153911025 @default.
• W2044349239 hasConcept C180754005 @default.
• W2044349239 hasConcept C189235521 @default.
• W2044349239 hasConcept C190727270 @default.
• W2044349239 hasConcept C203014093 @default.
• W2044349239 hasConcept C204232928 @default.
• W2044349239 hasConcept C2776192174 @default.
• W2044349239 hasConcept C2776750431 @default.
• W2044349239 hasConcept C2778264664 @default.
• W2044349239 hasConcept C2779767149 @default.
• W2044349239 hasConcept C33288867 @default.
• W2044349239 hasConcept C36823959 @default.
• W2044349239 hasConcept C502942594 @default.
• W2044349239 hasConcept C526805850 @default.
• W2044349239 hasConcept C54355233 @default.
• W2044349239 hasConcept C555283112 @default.
• W2044349239 hasConcept C61320498 @default.
• W2044349239 hasConcept C86803240 @default.
• W2044349239 hasConceptScore W2044349239C104317684 @default.
• W2044349239 hasConceptScore W2044349239C121608353 @default.
• W2044349239 hasConceptScore W2044349239C140173407 @default.
• W2044349239 hasConceptScore W2044349239C150194340 @default.

• next